Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Mental Health/Neurology 4,090 headlines found

4 Views

Europe lifts warning on Pfizer smoking cessation drug

European regulators have lifted a warning on Pfizer's smoking cessation drug Champix - called Chantix in the United States - after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects.
Reuters
added May 23, 2016 18:45
4 Views

Smoking Cessation Decelerates Brain Volume Loss in Multiple Sclerosis

Smoking cessation may help to decelerate brain volume loss in patients with multiple sclerosis (MS), according to data presented at the 2016 annual meeting of the American Academy of Neurology (AAN). Previous studies have indicated that smoking increases
Neurology Advisor
added Apr 25, 2016 14:27
4 Views

Debunked: Claims That Chantix And Zyban Smoking Cessation Drugs Boost Risk Of Psychiatric Side Effects

The smoking cessation aids varenicline (Chantix) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events compared to the nicotine patch and a placebo, according to data published in The Lancet. After reports claiming v
Science 2.0
added Apr 24, 2016 23:42
4 Views

Study: No suicide risk for anti-smoking pills Chantix, Zyban

Seven years after U.S. regulators slapped their strictest warning on two popular smoking-cessation medicines citing risks of suicidal behavior, a large international study found no such risk. Now Chantix maker Pfizer and Zyban maker GlaxoSmithKline hope
AP - Associated Press
added Apr 23, 2016 22:57
4 Views

[UK-Northern Ireland] Some mental health units in Northern Ireland to allow smoking while review is undertaken

The South Eastern Trust has agreed to temporarily lift the prohibition while a review is undertaken. Inpatients at some mental health units in Northern Ireland are to be exempt from the ban on smoking on hospital grounds. The South Eastern Trust has agre
BBC Online
added Apr 22, 2016 16:34
4 Views

Smoking and schizophrenia: Understanding and breaking the cycle of addiction University of Montreal

Smoking addiction in schizophrenia can be explained by significantly increased activation of the ventro-medial prefrontal cortex (vmPFC), a region involved in the brain reward system. These new data, the result of a study by researchers at the Institut un
EurekAlert
added Apr 18, 2016 22:36
4 Views

[UK] The Stolen Years / The Mental Health and Smoking Action Report.

ASH London (uk)
added Apr 14, 2016 14:25
4 Views

[UK-Scotland] DUFFY: How can smoking be a lifestyle choice when most want to stop?

The clear implication is that we must reject any suggestion of blaming people for their “lifestyle choices”, health or poverty. Nor should we abandon people... Scotland’s next administration should commit to concerted action across government departments
The Scotsman (uk)
added Apr 6, 2016 14:27
4 Views

[UK] Health Matters: Health inequalities and dementia

Smoking has been identified as the single biggest cause of inequality in death rates between rich and poor in the UK. Smoking is one of the biggest risk factors for dementia and studies suggest that it can double the risk of developing the condition.
Gov.uk Blogs (uk)
added Mar 22, 2016 11:01
4 Views

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant Pharmaceuticals for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) for 18 Central and Eastern European Countries and Turkey

Serious neuropsychiatric reactions have occurred in patients taking bupropion for smoking cessation...Although CONTRAVE is not approved for smoking cessation, observe all patients for neuropsychiatric reactions. Instruct the patient to contact a healthcar
PR Newswire
added Mar 15, 2016 15:31
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines